跳至主要内容
临床试验/IRCT20191230045950N2
IRCT20191230045950N2招募中3 期

Comparison of Ivabradine effect versus placebo on ventricular rate in patients with non-paroxysmal atrial fibrillation under standard medical treatment

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Non-paroxysmal atrial fibrillation at randomization, with no prospect of cardioversion, anti arrhythmic treatment with group I or III drugs, or pulmonary vein ablation
  • Beta-blocker or nondihydropyridine calcium channel blocker or digoxin therapy at the maximum dose recommended for or tolerated by the patient
  • Ventricular rate of more than 70
  • Be able to voluntarily give informed consent

排除标准

  • Medical causes that explain poor heart rate control: fever, anemia, hyperthyroidism ,etc
  • Patients with a known contraindication to Ivabradine
  • Valve disease requiring surgical or percutaneous repair
  • Impossibility to attend the visits scheduled in the protocol

研究者

相似试验

已完成
不适用
The effect of ivabradine on hemodynamics in patients with chronic heart failureCirculatory SystemIschaemic cardiomyopathyChronic heart failure
ISRCTN87590288Faculty Hospital Olomouc (Czech Republic)50
尚未招募
Unknown
Efficacy & safety of Ivabradine versus Beta blocker in Inappropriate Sinus Tachycardia
CTRI/2023/06/054179Kasturba Medical College, Manipal
进行中(未招募)
不适用
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 18.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849
EUCTR2012-002742-20-PTInstitut de Recherches Internationales Servier400
进行中(未招募)
1 期
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 18.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849
EUCTR2012-002742-20-DEInstitut de Recherches Internationales Servier400
进行中(未招募)
1 期
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 17.0Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849
EUCTR2012-002742-20-ATInstitut de Recherches Internationales Servier400